VINCENZI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 9.615
EU - Europa 2.823
AS - Asia 2.067
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 14.529
Nazione #
US - Stati Uniti d'America 9.579
CN - Cina 989
IT - Italia 803
SG - Singapore 534
UA - Ucraina 506
DE - Germania 420
TR - Turchia 372
PL - Polonia 337
GB - Regno Unito 264
SE - Svezia 166
FI - Finlandia 143
ID - Indonesia 101
FR - Francia 46
CA - Canada 36
BE - Belgio 35
CZ - Repubblica Ceca 26
RU - Federazione Russa 25
VN - Vietnam 23
HK - Hong Kong 19
NL - Olanda 13
EU - Europa 8
LT - Lituania 8
AT - Austria 7
CL - Cile 6
IN - India 6
JP - Giappone 6
BR - Brasile 5
IE - Irlanda 5
AU - Australia 4
HU - Ungheria 4
IR - Iran 4
KR - Corea 4
RO - Romania 4
CH - Svizzera 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
MY - Malesia 1
NO - Norvegia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 14.529
Città #
Fairfield 1.187
Woodbridge 1.155
Chandler 795
Ann Arbor 709
Houston 706
Ashburn 638
Jacksonville 615
Seattle 488
Wilmington 469
Cambridge 421
Singapore 407
Santa Clara 346
Warsaw 336
Ferrara 312
Izmir 234
Beijing 231
Nanjing 168
Princeton 163
Shanghai 128
Milan 113
Boardman 111
San Diego 105
Jakarta 100
Los Angeles 78
New York 59
Bremen 57
Nanchang 52
Shenyang 49
Dearborn 47
Tianjin 45
Hebei 36
London 36
Jiaxing 35
Brussels 34
Falls Church 34
Changsha 28
Munich 28
Bologna 27
Auburn Hills 24
Helsinki 24
Brno 23
Norwalk 23
Dong Ket 22
Zhengzhou 22
Mountain View 21
Toronto 21
Washington 20
Frankfurt am Main 19
Hong Kong 18
Des Moines 16
Guangzhou 16
Jinan 16
Kunming 16
Orange 16
Addison 14
Ferrara di Monte Baldo 14
Redwood City 14
San Mateo 13
Ningbo 12
Tappahannock 12
Ottawa 11
Augusta 10
Indiana 8
Chicago 7
Espoo 7
Kilburn 7
Rome 7
Hangzhou 6
Montebelluna 6
San Francisco 6
Venice 6
Aversa 5
Haikou 5
Las Vegas 5
Philadelphia 5
San Antonio 5
Taizhou 5
Tokyo 5
Verona 5
Bari 4
Cagliari 4
Castelnuovo di Porto 4
Chiswick 4
Dublin 4
Genoa 4
Hefei 4
Leawood 4
Padova 4
Redmond 4
Vienna 4
Walnut 4
Brescia 3
Budapest 3
Buffalo 3
Changchun 3
Chatsworth 3
Chongqing 3
Clifton 3
Florence 3
Hounslow 3
Totale 11.174
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 236
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 196
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 186
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 168
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 168
The A3 adenosine receptor: history and perspectives 166
Pharmacology of Adenosine Receptors: The State of the Art 164
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 157
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 156
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 149
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 149
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 146
Pathological overproduction: the bad side of adenosine 145
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 144
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 140
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 140
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 135
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 134
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 132
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 131
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 129
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 129
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 127
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 127
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 127
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 127
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 126
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 125
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 124
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 124
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 124
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 123
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 123
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 122
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 122
null 121
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 120
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 119
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 119
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 119
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 116
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 115
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 114
The role of adenosine receptors in rheumatoid arthritis. 113
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 113
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 112
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 112
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 112
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 111
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 110
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 110
null 107
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study. 106
null 106
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 105
null 104
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 103
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 103
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 102
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 101
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 99
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 95
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 95
null 94
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 94
Targeting A3 and A2A adenosine receptors in the fight against cancer 94
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 93
null 93
null 92
Anxiolytic properties of A1 adenosine receptor PAMs 92
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 92
null 91
null 91
Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes. 90
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 89
Development of novel pyridazinone-based adenosine receptor ligands 89
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 88
null 88
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 88
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 87
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 87
null 86
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 86
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 85
null 84
null 83
null 83
null 83
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 83
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 82
null 81
null 81
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 81
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 80
null 79
Effect of Pulsed Electromagnetic Field Exposure on Adenosine Receptors in Human Fibroblast-like Synoviocytes 79
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 79
ST 1535: A preferential A2A adenosine receptor antagonist 77
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 77
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 75
Totale 11.259
Categoria #
all - tutte 73.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.290
Totale 74.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.775 0 0 0 0 170 315 265 288 234 295 152 56
2020/20212.582 147 157 105 260 194 254 186 321 111 423 289 135
2021/20221.497 46 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20251.347 109 151 374 288 425 0 0 0 0 0 0 0
Totale 14.892